Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease

Molecular Psychiatry

Volumn 7, Issue 8, 2002, Pages 899-902

  Kölsch, Heike ^a   Lutjohann D ^a   Ludwig, M ^a   Schulte, A ^a   Ptok, U ^a   Jessen, F ^a   Von Bergmann, K ^a   Rao, M L ^a   Maier, W ^a   Heun, R ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

24S hydroxycholesterol; Alzheimer; Association; Brain cholesterol; Cerebrospinal fluid; CYP46; Cytochrome P450; Dementia; Neurodegeneration; Oxysterol

Indexed keywords

CHOLESTEROL 24 HYDROXYLASE; CHOLESTEROL DERIVATIVE; UNCLASSIFIED DRUG;

ALLELE; ALZHEIMER DISEASE; ARTICLE; BRAIN METABOLISM; CHOLESTEROL METABOLISM; DISEASE PREDISPOSITION; DNA POLYMORPHISM; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ALZHEIMER DISEASE; CELL DEATH; CHOLESTEROL; FEMALE; HUMANS; HYDROXYCHOLESTEROLS; MALE; MIDDLE AGED; NEURONS; POLYMORPHISM, GENETIC; STEROID HYDROXYLASES;

EID: 0036384169     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001109     Document Type: Article

References (28)

1. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993; 90: 1977-1981.
2. Notkola IL, Sulkava R, Pekkanen J, Erkinjuntti T, Ehnholm C, Kivinen P et al. Serum total cholesterol, apolipoprotein E ε4 allele, and Alzheimer's disease. Neuroepidemiology 1998; 17: 14-20.
3. Dupuy AM, Mas E, Ritchie K, Descomps B, Badiou S, Cristol JP, Touchon J. The relationship between apolipoprotein E4 and lipid metabolism is impaired in Alzheimer's disease. Gerontology 2001; 47: 213-218.
4. Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 2001; 322: 1447-1451.
5. Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G. Decreased prevalence of Alzheimer disease associated with 3-hydroxy -3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 2000; 57: 1439-1443.
6. Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA. Statins and the risk of dementia. Lancet 2000; 356: 1627-1631.
7. Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K. Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons. Proc Natl Acad Sci USA 1998; 95: 6460-6464.
8. Fassbender K, Simons M, Bergmann C, Stroick M, Lütjohann D, Keller P et al. Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci USA 2001; 98: 5856-5861.
9. Jurevics H, Morell P. Cholesterol for synthesis of myelin is made locally, not imported into the brain. J Neurochem 1995; 64: 895-901.
10. Goodrum JF. Cholesterol from degenerating nerve myelin becomes associated with lipoproteins containing apolipoprotein E. J Neurochem 1991; 56: 2082-2086.
11. Björkhem I, Lütjohann D, Breuer O, Sakinis A, Wennmalm A. Importance of a novel oxidative mechanism for elimination of brain cholesterol. J Biol Chem 1997; 48: 30178-30184.
12. DiFrisco S, De Ruggieri P. Isolation of cerebrosterol from human brain. Bull Soc Ital Biol Sper 1953; 29: 1351-1352.
13. Björkhem I, Lütjohann D, Diczfalusy U, Stahle L, Ahlborg G, Wahren J. Cholesterol homeostasis in human brain: turnover of 24S-hydroperoxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J Lipid Res 1998; 39: 1594-1600.
14. Kölsch H, Lütjohann D, Tulke A, Björkhem I, Rao ML. The neurotoxic effect of 24-hydroxycholesterol on SH-SY5Y human neuroblastoma cells. Brain Res 1999; 818: 171-175.
15. Kölsch H, Ludwig M, Lütjohann D, Rao ML. Neurotoxicity of 24-hydroxycholesterol, an important cholesterol elimination product of the brain, may be prevented by vitamin E and estradiol-17β. J Neural Transm 2001; 108: 475-488.
16. Lütjohann D, Papassotiropoulos A, Björkhem I, Locatelli A, Bagli M, Oehring RD et al. Plasma 24-S-hydroxy-cholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J Lipid Res 1999; 41: 195-198.
17. Papassotiropoulos A, Lütjohann D, Bagli M, Locatelli S, Jessen F, Buschfort R et al. 24S-Hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. Psychiatr Res 2002; 36: 27-32.
18. Papassotiropoulos A, Lütjohann D, Bagli M, Locatelli S, Jessen F, Rao ML et al. Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease. Neureport 2000; 2: 1-4.
19. Lund EG, Guileyardo JM, Russell DW. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc Natl Acad Sci USA 1999; 96: 7238-7243.
20. Garpenstrand H, Ekblom J, Forslund K, Rylander G, Oreland L. Platelet monoamine oxidase activity is related to MAOB intron 13 genotype. J Neural Transm 2000; 107: 523-530.
21. Krainer A, Maniatis T. RNA splicing. IRL Press: Oxford, 1988, pp 131-206.
22. Bretillon L, Siden A, Wahlund LO, Lütjohann D, Minthon L, Crisby M et al. Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases. Neurosci Lett 2000; 293: 87-90.
23. Lovell MA, Markesbery WR. Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid. Arch Neurol 2001; 58: 392-396.
24. Ramassamy C, Averill D, Beffert U, Bastianetto S, Theroux L, Lussier-Cacan S et al. Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype. Free Radic Biol Med 1999; 27: 544-553.
25. Anderson KM, Seed T, Ou D, Harris JE. Free radicals and reactive oxygen species in programmed cell death. Med Hypotheses 1999; 52: 451-463.
26. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
27. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990; 31: 545-548.
28. Dzeletovic S, Breuer O, Lund E, Diczfalusy U. Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal Biochem 1995; 225: 73-80.